Citizens lowered the firm's price target on Wealthfront to $17 from $20 and keeps an Outperform rating on the shares. Recent share weakness appears more technical than fundamental, as Wealthfront delivered Q4 results modestly above expectations with $96M in revenue and $44M in adjusted EBITDA, the analyst tells investors in a research note.
